Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
189.9 HKD | +1.61% | +3.88% | +10.79% |
04-26 | National Bank Previews Lifecos' Q1, Cuts IAG Q1 Forecast by 5% | MT |
04-17 | TSX Closer: Market Manages To Finish Up 13 Points After MIdday Plunge | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.72 for the current year.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.84 for the current period. Therefore, the company is undervalued.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Historically, the company has been releasing figures that are above expectations.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.79% | 43.12B | - | ||
+9.22% | 74.49B | B- | ||
+7.65% | 50.15B | B+ | ||
+2.70% | 47.28B | B | ||
+11.14% | 40.31B | B+ | ||
+22.17% | 38.48B | B | ||
+5.72% | 30.54B | B | ||
-1.21% | 28.79B | B- | ||
+11.26% | 22.81B | A | ||
+21.09% | 22.66B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MFC Stock
- 945 Stock
- Ratings Manulife Financial Corporation